BALAXI PHARMACEUTICALS LIMITED (BALAXI) — Free Cash Flow Generation Index
BALAXI PHARMACEUTICALS LIMITED (BALAXI) has a Free Cash Flow Generation Index of 0.17x as of September 2025. Free cash flow of Rs25.78 Million represents 0% of operating cash flow (Rs149.66 Million). Explore BALAXI PHARMACEUTICALS LIMITED capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
BALAXI PHARMACEUTICALS LIMITED Free Cash Flow Generation Index (2013–2024)
Historical FCF Generation Index trend for BALAXI PHARMACEUTICALS LIMITED across 6 annual periods. For the full cash flow conversion analysis, see BALAXI PHARMACEUTICALS LIMITED cash conversion from operations.
Annual Free Cash Flow Generation for BALAXI PHARMACEUTICALS LIMITED (2013–2024)
Year-by-year Free Cash Flow Generation Index for BALAXI PHARMACEUTICALS LIMITED. Check BALAXI PHARMACEUTICALS LIMITED (BALAXI) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (INR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.68x | Rs32.97 Million | Rs48.66 Million | Rs15.69 Million | ▲ +146.2% |
| 2023 | -1.47x | Rs-89.05 Million | Rs60.75 Million | Rs149.80 Million | ▼ -835.9% |
| 2022 | 0.20x | Rs68.00 Million | Rs341.44 Million | Rs273.44 Million | ▲ +100.0% |
| 2021 | -823.61x | Rs-25.53 Million | Rs31.00K | Rs25.56 Million | ▼ -83636.6% |
| 2015 | 0.99x | Rs2.08 Million | Rs2.11 Million | Rs29.72K | ▼ -1.4% |
| 2013 | 1.00x | Rs3.25 Million | Rs3.25 Million | Rs0.00 | — |